Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Flynn James E | Director, 10% Owner | 21 | $5.70M | $125.9K | 2022-12-30 |
| Deerfield Mgmt HIF, L.P. | 10% Owner | 6 | $0 | $19.9K | 2022-12-27 |
| Deerfield Healthcare Innovations Fund, L.P. | Director, 10% Owner | 22 | $15.00M | $5.3K | 2022-12-15 |
| Harbin Stephen | COO and Chief of Staff | 6 | $173.7K | $0 | 2022-11-01 |
| Rubin Eric | Director | 2 | $0 | $0 | 2022-06-23 |
| Nam Spencer | Director | 4 | $0 | $0 | 2022-06-23 |
| Yanni Barbara | Director | 2 | $0 | $0 | 2022-06-23 |
| Finer Mitchell H. | Director | 3 | $0 | $0 | 2022-06-23 |
| Fenton Mary Kay | Director | 2 | $0 | $0 | 2022-06-23 |
| Canute Scott A | Director | 4 | $0 | $0 | 2022-06-23 |
| EVNIN LUKE | Director, 10% Owner | 7 | $2.27M | $0 | 2022-06-23 |
| FAMBROUGH DOUGLAS | Director | 1 | $0 | $0 | 2022-06-22 |
| Wanstall Rick | CFO and Treasurer | 8 | $57.0K | $0 | 2022-05-25 |
| Goldberg John Mayer | SVP, Clinical Development | 3 | $0 | $0 | 2022-03-01 |
| Queva Christophe | CSO and SVP, Research | 13 | $0 | $1.13M | 2022-03-01 |
| McCabe John P. | CFO, Treasurer and Secretary | 2 | $0 | $0 | 2022-03-01 |
| Ashburn Theodore | President and CEO | 11 | $0 | $0 | 2022-03-01 |
| MPM SunStates Fund, L.P. | 10% Owner | 5 | $2.61M | $0 | 2020-10-06 |
| MPM Oncology Impact Management GP LLC | 10% Owner | 5 | $2.27M | $0 | 2020-10-06 |
| MPM Asset Management Investors BV2014 LLC | 10% Owner | 5 | $2.61M | $0 | 2020-10-06 |
| GADICKE ANSBERT | 10% Owner | 10 | $4.88M | $0 | 2020-10-06 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Flynn James E | 10% Owner | S Sale | 2022-12-30 | 2022-12-30 | 15,220 | $0.27 | $4.1K | 284,697 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-30 | 2022-12-30 | 61,826 | $0.27 | $16.7K | 1,156,309 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-30 | 2022-12-30 | 61,826 | $0.27 | $16.7K | 1,156,308 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-29 | 2022-12-30 | 63,107 | $0.26 | $16.4K | 1,218,135 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-29 | 2022-12-30 | 63,108 | $0.26 | $16.4K | 1,218,134 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-29 | 2022-12-30 | 15,538 | $0.26 | $4.0K | 299,917 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-28 | 2022-12-30 | 24,757 | $0.25 | $6.2K | 1,281,242 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-28 | 2022-12-30 | 6,096 | $0.25 | $1.5K | 315,455 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-28 | 2022-12-30 | 24,757 | $0.25 | $6.2K | 1,281,242 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | 10% Owner | S Sale | 2022-12-27 | 2022-12-27 | 7,136 | $0.27 | $1.9K | 321,551 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | 10% Owner | S Sale | 2022-12-27 | 2022-12-27 | 28,977 | $0.27 | $7.8K | 1,305,999 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | 10% Owner | S Sale | 2022-12-27 | 2022-12-27 | 28,977 | $0.27 | $7.8K | 1,305,999 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | 10% Owner | S Sale | 2022-12-22 | 2022-12-27 | 3,693 | $0.28 | $1.0K | 1,334,976 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | 10% Owner | S Sale | 2022-12-22 | 2022-12-27 | 3,692 | $0.28 | $1.0K | 1,334,976 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | 10% Owner | S Sale | 2022-12-22 | 2022-12-27 | 909 | $0.28 | $255 | 328,687 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-21 | 2022-12-21 | 6,144 | $0.30 | $1.8K | 1,338,668 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-21 | 2022-12-21 | 6,143 | $0.30 | $1.8K | 1,338,669 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-21 | 2022-12-21 | 1,513 | $0.30 | $454 | 329,596 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-20 | 2022-12-21 | 1,616 | $0.31 | $501 | 331,109 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-20 | 2022-12-21 | 6,562 | $0.31 | $2.0K | 1,344,812 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-20 | 2022-12-21 | 6,562 | $0.31 | $2.0K | 1,344,812 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-19 | 2022-12-21 | 44,394 | $0.29 | $12.9K | 1,351,374 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-19 | 2022-12-21 | 44,394 | $0.29 | $12.9K | 1,351,374 | SEC↗ |
| Flynn James E | 10% Owner | S Sale | 2022-12-19 | 2022-12-21 | 10,930 | $0.29 | $3.2K | 332,725 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-15 | 2022-12-15 | 1,375 | $0.39 | $536 | 1,395,768 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-15 | 2022-12-15 | 339 | $0.39 | $132 | 343,655 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-15 | 2022-12-15 | 1,375 | $0.39 | $536 | 1,395,768 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-14 | 2022-12-15 | 943 | $0.38 | $358 | 343,994 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-14 | 2022-12-15 | 3,829 | $0.38 | $1.5K | 1,397,143 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-14 | 2022-12-15 | 3,828 | $0.38 | $1.5K | 1,397,143 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-13 | 2022-12-15 | 934 | $0.41 | $383 | 1,400,971 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-13 | 2022-12-15 | 933 | $0.41 | $383 | 1,400,972 | SEC↗ |
| Deerfield Healthcare Innovatio | 10% Owner | S Sale | 2022-12-13 | 2022-12-15 | 230 | $0.41 | $94 | 344,937 | SEC↗ |
| Harbin Stephen | COO and Chief of Staff | A Award deriv | 2022-11-01 | 2022-11-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Finer Mitchell H. | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Canute Scott A | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EVNIN LUKE | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Fenton Mary Kay | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Nam Spencer | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Rubin Eric | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Yanni Barbara | Director | A Award deriv | 2022-06-23 | 2022-06-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| FAMBROUGH DOUGLAS | Director | A Award deriv | 2022-06-22 | 2022-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Wanstall Rick | CFO and Treasurer | P Buy | 2022-05-25 | 2022-05-25 | 3,777 | $1.20 | $4.5K | 51,000 | SEC↗ |
| Wanstall Rick | CFO and Treasurer | P Buy | 2022-05-20 | 2022-05-24 | 1,610 | $1.20 | $1.9K | 47,223 | SEC↗ |
| Wanstall Rick | CFO and Treasurer | P Buy | 2022-05-19 | 2022-05-19 | 5,000 | $1.29 | $6.5K | 45,613 | SEC↗ |
| Wanstall Rick | CFO and Treasurer | P Buy | 2022-05-17 | 2022-05-19 | 1 | $1.20 | $1 | 40,613 | SEC↗ |
| Wanstall Rick | CFO and Treasurer | P Buy | 2022-05-16 | 2022-05-16 | 20,620 | $1.18 | $24.3K | 40,612 | SEC↗ |
| Wanstall Rick | CFO and Treasurer | P Buy | 2022-05-13 | 2022-05-16 | 3,898 | $1.15 | $4.5K | 19,992 | SEC↗ |
| Wanstall Rick | CFO and Treasurer | P Buy | 2022-05-12 | 2022-05-16 | 14,094 | $1.08 | $15.2K | 16,094 | SEC↗ |
| Wanstall Rick | CFO and Treasurer | A Award deriv | 2022-05-10 | 2022-05-12 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Ashburn Theodore | President and CEO | A Award deriv | 2022-03-01 | 2022-03-02 | 211,000 | — | $0 | 211,000 | SEC↗ |
| Harbin Stephen | COO and Chief of Staff | A Award deriv | 2022-03-01 | 2022-03-02 | 87,500 | — | $0 | 87,500 | SEC↗ |
| McCabe John P. | CFO and Treasurer | A Award deriv | 2022-03-01 | 2022-03-02 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | A Award deriv | 2022-03-01 | 2022-03-02 | 82,500 | — | $0 | 82,500 | SEC↗ |
| Goldberg John Mayer | Chief Medical Officer | A Award deriv | 2022-03-01 | 2022-03-02 | 84,500 | — | $0 | 84,500 | SEC↗ |
| Ashburn Theodore | President and CEO | M Exercise deriv | 2021-11-19 | 2021-11-22 | 32,500 | — | $0 | 255,768 | SEC↗ |
| Ashburn Theodore | President and CEO | M Exercise | 2021-11-19 | 2021-11-22 | 32,500 | $1.81 | $58.8K | 99,352 | SEC↗ |
| Harbin Stephen | COO and Chief of Staff | P Buy | 2021-11-16 | 2021-11-17 | 15,000 | $5.80 | $87.0K | 15,000 | SEC↗ |
| Harbin Stephen | COO and Chief of Staff | P Buy | 2021-11-16 | 2021-11-17 | 15,000 | $5.78 | $86.7K | 15,000 | SEC↗ |
| Ashburn Theodore | President and CEO | M Exercise deriv | 2021-10-22 | 2021-10-25 | 43,707 | — | $0 | 288,268 | SEC↗ |
| Ashburn Theodore | President and CEO | M Exercise | 2021-10-22 | 2021-10-25 | 43,707 | $1.81 | $79.1K | 66,852 | SEC↗ |
| Yanni Barbara | Director | A Award deriv | 2021-07-27 | 2021-07-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Rubin Eric | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Finer Mitchell H. | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Nam Spencer | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Canute Scott A | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| EVNIN LUKE | Director, 10% Owner | A Award deriv | 2021-06-16 | 2021-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Fenton Mary Kay | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Harbin Stephen | COO and Chief of Staff | A Award deriv | 2021-06-15 | 2021-06-17 | 87,125 | — | $0 | 87,125 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | S Sale | 2021-06-02 | 2021-06-03 | 10,656 | $16.66 | $177.5K | 47,626 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | S Sale | 2021-06-01 | 2021-06-03 | 12,899 | $16.69 | $215.3K | 58,282 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | M Exercise deriv | 2021-05-24 | 2021-05-26 | 35,561 | — | $0 | 17,781 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | M Exercise | 2021-05-24 | 2021-05-26 | 35,561 | $1.81 | $64.4K | 71,181 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | S Sale | 2021-04-30 | 2021-05-04 | 800 | $16.76 | $13.4K | 35,620 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | S Sale | 2021-04-30 | 2021-05-04 | 22,755 | $15.94 | $362.7K | 36,420 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | S Sale | 2021-04-28 | 2021-04-28 | 17,990 | $15.22 | $273.8K | 59,175 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | S Sale | 2021-04-27 | 2021-04-28 | 211 | $15.00 | $3.2K | 77,165 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | S Sale | 2021-04-26 | 2021-04-28 | 54 | $15.00 | $810 | 77,376 | SEC↗ |
| Ashburn Theodore | President and CEO | M Exercise deriv | 2021-04-07 | 2021-04-09 | 4,699 | — | $0 | 336,546 | SEC↗ |
| Ashburn Theodore | President and CEO | M Exercise | 2021-04-07 | 2021-04-09 | 4,699 | $5.32 | $25.0K | 23,145 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | S Sale | 2021-04-06 | 2021-04-08 | 5,300 | $15.01 | $79.6K | 77,430 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | A Award deriv | 2021-03-01 | 2021-03-03 | 70,109 | — | $0 | 70,109 | SEC↗ |
| Ashburn Theodore | President and CEO | A Award deriv | 2021-03-01 | 2021-03-03 | 199,000 | — | $0 | 199,000 | SEC↗ |
| Goldberg John Mayer | SVP, Clinical Development | A Award deriv | 2021-03-01 | 2021-03-03 | 61,063 | — | $0 | 61,063 | SEC↗ |
| McCabe John P. | CFO, Treasurer and Secretary | A Award deriv | 2021-03-01 | 2021-03-03 | 76,894 | — | $0 | 76,894 | SEC↗ |
| Flynn James E | Director, 10% Owner | P Buy | 2021-02-17 | 2021-02-18 | 32,884 | $19.00 | $624.8K | 345,167 | SEC↗ |
| Flynn James E | Director, 10% Owner | P Buy | 2021-02-17 | 2021-02-18 | 133,558 | $19.00 | $2.54M | 1,401,905 | SEC↗ |
| Flynn James E | Director, 10% Owner | P Buy | 2021-02-17 | 2021-02-18 | 133,558 | $19.00 | $2.54M | 1,401,905 | SEC↗ |
| Ashburn Theodore | President and CEO | M Exercise deriv | 2020-12-31 | 2021-04-09 | 1,900 | — | $0 | 331,975 | SEC↗ |
| Ashburn Theodore | President and CEO | M Exercise | 2020-12-31 | 2021-04-09 | 1,900 | $1.81 | $3.4K | 18,446 | SEC↗ |
| Canute Scott A | Director | A Award deriv | 2020-12-11 | 2021-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Canute Scott A | Director | A Award deriv | 2020-12-11 | 2020-12-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Harbin Stephen | COO and Chief of Staff | A Award deriv | 2020-12-07 | 2020-12-09 | 169,000 | — | $0 | 169,000 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 7,499,999 | — | $0 | 0 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 7,499,999 | — | $0 | 0 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 2,449,761 | — | $0 | 0 | SEC↗ |
| MPM Oncology Impact Management | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,525,348 | — | $0 | 0 | SEC↗ |
| MPM Oncology Impact Management | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 700,453 | — | $0 | 0 | SEC↗ |
| EVNIN LUKE | Director, 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,525,346 | — | $0 | 0 | SEC↗ |
| EVNIN LUKE | Director, 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 700,449 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 700,453 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 0 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,525,348 | — | $0 | 0 | SEC↗ |
| Finer Mitchell H. | Director | A Award deriv | 2020-10-06 | 2020-10-08 | 42,970 | — | $0 | 42,970 | SEC↗ |
| MPM Asset Management Investors | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 0 | SEC↗ |
| MPM Asset Management Investors | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 0 | SEC↗ |
| Nam Spencer | Director | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,924 | — | $0 | 0 | SEC↗ |
| MPM SunStates Fund, L.P. | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 0 | SEC↗ |
| MPM SunStates Fund, L.P. | 10% Owner | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 0 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 823,150 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 445,194 | $15.00 | $6.68M | 1,268,344 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 445,194 | $15.00 | $6.68M | 1,268,344 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 202,670 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 109,612 | $15.00 | $1.64M | 312,282 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 202,670 | — | $0 | 823,150 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 620,480 | — | $0 | 620,480 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 620,480 | — | $0 | 620,480 | SEC↗ |
| MPM Oncology Impact Management | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 700,453 | — | $0 | 2,225,801 | SEC↗ |
| MPM Oncology Impact Management | 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 151,224 | $15.00 | $2.27M | 2,377,025 | SEC↗ |
| MPM Oncology Impact Management | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 1,525,348 | — | $0 | 1,525,348 | SEC↗ |
| EVNIN LUKE | Director, 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 700,449 | — | $0 | 2,341,618 | SEC↗ |
| EVNIN LUKE | Director, 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 151,225 | $15.00 | $2.27M | 2,492,843 | SEC↗ |
| EVNIN LUKE | Director, 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 1,525,346 | — | $0 | 1,641,169 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 2,675,677 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 173,776 | $15.00 | $2.61M | 2,849,453 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 700,453 | — | $0 | 2,225,801 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 151,224 | $15.00 | $2.27M | 2,377,025 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 1,525,348 | — | $0 | 1,525,348 | SEC↗ |
| GADICKE ANSBERT | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 1,899,702 | SEC↗ |
| MPM Asset Management Investors | 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 173,776 | $15.00 | $2.61M | 2,849,453 | SEC↗ |
| MPM Asset Management Investors | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 1,899,702 | SEC↗ |
| MPM Asset Management Investors | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 2,675,677 | SEC↗ |
| Nam Spencer | Director | C Conversion | 2020-10-06 | 2020-10-08 | 1,924 | — | $0 | 1,924 | SEC↗ |
| MPM SunStates Fund, L.P. | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 2,675,677 | SEC↗ |
| MPM SunStates Fund, L.P. | 10% Owner | P Buy | 2020-10-06 | 2020-10-08 | 173,776 | $15.00 | $2.61M | 2,849,453 | SEC↗ |
| MPM SunStates Fund, L.P. | 10% Owner | C Conversion | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 1,899,702 | SEC↗ |
| Goldberg John Mayer | SVP, Clinical Development | A Award deriv | 2020-10-01 | 2020-10-05 | 56,285 | — | $0 | 56,285 | SEC↗ |
| Ashburn Theodore | President and CEO | A Award deriv | 2020-10-01 | 2020-10-05 | 126,624 | — | $0 | 126,624 | SEC↗ |
| Queva Christophe | CSO and SVP, Research | A Award deriv | 2020-10-01 | 2020-10-05 | 89,725 | — | $0 | 89,725 | SEC↗ |